Efficacy and Safety of Second-Line Agents for Treatment of Metastatic Castration-Resistant Prostate Cancer Progressing After Docetaxel. A Systematic Review and Meta-Analysis. Arch Ital Urol Androl 2015, 87 (2), 121-129. https://doi.org/10.4081/aiua.2015.2.121.